Lamotrigine in the treatment of SUNCT syndrome.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 11706123.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Short-lasting, unilateral, neuralgiform headache attacks with conjunctival injection and tearing (SUNCT) is considered an intractable condition. The authors treated five patients with lamotrigine (125 to 200 mg daily), obtaining a complete remission in three patients and a substantial reduction (about 80%) of attack frequency in the other two. No adverse effects were noted.
Medical subject headings
- Analgesics
- Headache Disorders
- Triazines